Home » Archive

Featured, News, San Diego Biotech Jobs, SDBN Blog »

New Feature on the SDBN Website: Top News & Jobs

Posted by Mary Canady July 27th, 2012 .
No Comments

Each week we chronicle San Diego Biotechnology news, events, and jobs. Now, we’ll provide you with the top news and jobs each week at the end of the day Thursday. The top news is determined by the popularity of items in our daily emails. The top jobs are the ones that are featured, contact us to learn how you can get your jobs listed here. Bookmark the pages below and check back on Fridays to see what’s hot in San Diego life science!
sdbn.org/topnews
sdbn.org/topjobs

More...

Marketwire, News, Syndication »

Cytori to Webcast Second Quarter Financial Results on August 8

Posted by Mary Canady July 26th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Jul 26, 2012) – Cytori Therapeutics (NASDAQ: CYTX) will provide a live webcast of its second quarter financial results and business update on Wednesday, August 8, 2012 at 5:00 PM Eastern Time.
The dial-in informa…

More...

Featured, SDBN Blog »

Building A Life Science Team To Meet Your Goals

Posted by Mary Canady July 24th, 2012 .
No Comments

Building a Life Science Team To Meet Your Goals from Mary Canady
Presentation by Mary Canady for the SDBN July 23rd Speed Networking event with hyperlinks and audio.

More...

Marketwire, News, Syndication »

Medistem Launches Critical Limb Ischemia Clinical Trial

Posted by Mary Canady July 13th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Jul 13, 2012) – Medistem Inc. (PINKSHEETS: MEDS) and the Chinese Conglomerate, Shanghai Jia Fu Medical Apparatus Inc, announced today successful administration of Medistem’s Endometrial Regenerative Cell (ERC) universal …

More...

Marketwire, News, Syndication »

Medistem to Give Keynote Address at International Gathering of Romanian Leaders

Posted by Mary Canady July 12th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Jul 12, 2012) – Medistem Inc. (PINKSHEETS: MEDS) announced today it has been chosen by the Romanian Cultural Association to give a keynote talk at its annual gathering in Hamilton, Canada.
The meeting, which is a…

More...

Marketwire, News, Syndication »

Quidel to Hold Second Quarter 2012 Financial Results Conference Call on July 25, 2012

Posted by Mary Canady July 10th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Jul 10, 2012) – Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions and cellular-based virology assays, will release second quarter 2012 financial results after market close on Wed…

More...

Headline, SDBN Blog, SDBN Events »

SDBN July 23rd Speed Networking: Build Your Team

Posted by Mary Canady July 2nd, 2012 .
No Comments

It’s time again for our ever popular speed networking event July 23rd! We hold this occasion semiannually and we always get a big, enthusiastic crowd. This time we’ll focus on helping you build the team which will help meet your goals. We’ll provide useful information and you’ll get the opportunity to connect with many biotech and life science professionals in a fun environment.
Building a team is important whether you’re looking for a job, searching for new clients, or just want to get to know people in the industry. At our …

More...

Marketwire, News, Syndication »

Medistem Receives Notice of Patent Allowance Covering Fat Stem Cell Therapy of Autoimmune Diseases

Posted by Mary Canady June 28th, 2012 .
No Comments

SAN DIEGO CA–(Marketwire – Jun 29, 2012) –  Medistem Inc. (PINKSHEETS: MEDS) announced today notice of allowance from the United States Patent and Trademark Office (USPTO) for a patent covering the use of fat stem cells, and cells associated with f…

More...

Marketwire, News, Syndication »

Medistem Receives Notice of Patent Allowance Covering Fat Stem Cell Therapy of Autoimmune Diseases

Posted by Mary Canady June 28th, 2012 .
No Comments

SAN DIEGO CA–(Marketwire – Jun 29, 2012) –  Medistem Inc. (PINKSHEETS: MEDS) announced today notice of allowance from the United States Patent and Trademark Office (USPTO) for a patent covering the use of fat stem cells, and cells associated with f…

More...

Marketwire, News, Syndication »

Genelux Corporation Announces Ground-Breaking Clinical Study Evaluating Oncolytic Vaccinia Virus in Canine Cancer Patients

Posted by Mary Canady June 28th, 2012 .
No Comments

SAN DIEGO, CA–(Marketwire – Jun 28, 2012) – Genelux Corporation, a clinical-stage biopharmaceutical company developing vaccinia virus-based oncolytic (cancer-killing) therapies and companion diagnostics for cancer, today announced the start of a gr…

More...